TreeWAS – Variant ID: rs1154053

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
R49.0 Dysphonia	0.000	0.984	0.016
M50.3 Other cervical disk degeneration	0.000	0.992	0.008
I27.0 Primary pulmonary hypertension	0.008	0.992	0.000
Z31.0 Tuboplasty or vasoplasty after previous sterilisation	0.007	0.993	0.000
C67 Malignant neoplasm of bladder	0.007	0.993	0.000
C67.5 Bladder neck	0.006	0.994	0.000
R49 Voice disturbances	0.000	0.994	0.006
C67.2 Lateral wall of bladder	0.006	0.994	0.000
C67.0 Trigone of bladder	0.006	0.994	0.000
C67.3 Anterior wall of bladder	0.006	0.994	0.000
Z90.2 Acquired absence of lung [part of]	0.006	0.994	0.000
D22.6 Melanocytic naevi of upper limb, including shoulder	0.006	0.994	0.000
C67.4 Posterior wall of bladder	0.006	0.994	0.000
F32.2 Severe depressive episode without psychotic symptoms	0.000	0.994	0.006
C67.6 Ureteric orifice	0.006	0.994	0.000
C67.8 Overlapping lesion of bladder	0.005	0.995	0.000
Z31 Procreative management	0.005	0.995	0.000
Z31.4 Procreative investigation and testing	0.005	0.995	0.000
Z85.1 Personal history of malignant neoplasm of trachea, bronchus and lung	0.005	0.995	0.000
C67.7 Urachus	0.005	0.995	0.000
C67.1 Dome of bladder	0.005	0.995	0.000
F32.3 Severe depressive episode with psychotic symptoms	0.000	0.995	0.005
F32 Depressive episode	0.000	0.995	0.005
R49.2 Hypernasality and hyponasality	0.000	0.995	0.005
R49.1 Aphonia	0.000	0.995	0.005
Z31.6 General counselling and advice on procreation	0.004	0.995	0.000
F30-F39 Mood [affective] disorders	0.000	0.995	0.005
Y42.5 Other oestrogens and progestogens	0.004	0.995	0.000
Z31.9 Procreative management, unspecified	0.004	0.996	0.000
Z31.3 Other assisted fertilisation methods	0.004	0.996	0.000
N11.9 Chronic tubulo-interstitial nephritis, unspecified	0.004	0.996	0.000
H35.8 Other specified retinal disorders	0.004	0.996	0.000
Z31.8 Other procreative management	0.004	0.996	0.000
F34 Persistent mood [affective] disorders	0.000	0.996	0.004
F34.1 Dysthymia	0.000	0.996	0.004
O42.9 Premature rupture of membranes, unspecified	0.004	0.996	0.000
Z31.5 Genetic counselling	0.004	0.996	0.000
Z31.1 Artifical insemination	0.004	0.996	0.000
F39 Unspecified mood [affective] disorder	0.000	0.996	0.004
F33.9 Recurrent depressive disorder, unspecified	0.000	0.996	0.004
F32.8 Other depressive episodes	0.000	0.996	0.004
F30 Manic episode	0.000	0.996	0.004
C66 Malignant neoplasm of ureter	0.004	0.996	0.000
F38 Other mood [affective] disorders	0.000	0.996	0.004
C64-C68 Malignant neoplasms of urinary tract	0.004	0.996	0.000
R49.8 Other and unspecified voice disturbances	0.000	0.996	0.004
Y42.0 Glucocorticoids and synthetic analogs	0.004	0.996	0.000
F33 Recurrent depressive disorder	0.000	0.996	0.004
Z31.2 In vitro fertilisation	0.003	0.996	0.000
F31 Bipolar affective disorder	0.000	0.996	0.004
F32.0 Mild depressive episode	0.000	0.996	0.003
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.000	0.996	0.003
Z42.0 Follow-up care involving plastic surgery of head and neck	0.003	0.997	0.000
J98.1 Pulmonary collapse	0.003	0.997	0.000
F34.9 Persistent mood [affective] disorder, unspecified	0.000	0.997	0.003
F34.8 Other persistent mood [affective] disorders	0.000	0.997	0.003
F30.2 Mania with psychotic symptoms	0.000	0.997	0.003
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.003	0.997	0.000
Y54.3 Benzothiadiazine derivatives	0.003	0.997	0.000
M31.6 Other giant cell arteritis	0.000	0.997	0.003
C68 Malignant neoplasm of other and unspecified urinary organs	0.003	0.997	0.000
F34.0 Cyclothymia	0.000	0.997	0.003
F31.8 Other bipolar affective disorders	0.000	0.997	0.003
F30.0 Hypomania	0.000	0.997	0.003
F38.0 Other single mood [affective] disorders	0.000	0.997	0.003
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.000	0.997	0.003
G00.1 Pneumococcal meningitis	0.000	0.997	0.003
I31.3 Pericardial effusion (noninflammatory)	0.000	0.997	0.003
Y54.5 Other diuretics	0.003	0.997	0.000
R91 Abnormal findings on diagnostic imaging of lung	0.003	0.997	0.000
F32.1 Moderate depressive episode	0.000	0.997	0.003
F38.8 Other specified mood [affective] disorders	0.000	0.997	0.003
F30.9 Manic episode, unspecified	0.000	0.997	0.003
F30.8 Other manic episodes	0.000	0.997	0.003
Z42.3 Follow-up care involving plastic surgery of upper extremity	0.003	0.997	0.000
Y54.4 Loop [high-ceiling] diuretics	0.003	0.997	0.000
F31.6 Bipolar affective disorder, current episode mixed	0.000	0.997	0.003
Z42 Follow-up care involving plastic surgery	0.003	0.997	0.000
F38.1 Other recurrent mood [affective] disorders	0.000	0.997	0.003
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
F30.1 Mania without psychotic symptoms	0.000	0.997	0.003
M84.03 Malunion of fracture (Forearm)	0.003	0.997	0.000
C68.9 Urinary organ, unspecified	0.003	0.997	0.000
Y54.8 Agents affecting uric acid metabolism	0.003	0.997	0.000
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.000	0.997	0.003
Z42.2 Follow-up care involving plastic surgery of other parts of trunk	0.003	0.997	0.000
Z42.4 Follow-up care involving plastic surgery of lower extremity	0.003	0.997	0.000
F31.7 Bipolar affective disorder, currently in remission	0.000	0.997	0.003
Y54.0 Mineralocorticoids	0.003	0.997	0.000
D07.5 Prostate	0.000	0.997	0.003
Y45.5 4-Aminophenol derivatives	0.003	0.997	0.000
Y54.7 Agents affecting calcification	0.003	0.997	0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.000	0.997	0.003
Y52.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.000	0.997	0.003
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
C67.9 Bladder, unspecified	0.003	0.997	0.000
C68.0 Urethra	0.003	0.997	0.000
F33.8 Other recurrent depressive disorders	0.000	0.997	0.003
Y42.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
Z42.8 Follow-up care involving plastic surgery of other body part	0.003	0.997	0.000
F33.4 Recurrent depressive disorder, currently in remission	0.000	0.997	0.002
Y54.9 Mineral salts, not elsewhere classified	0.003	0.997	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.003	0.997	0.000
M54.22 Cervicalgia (Cervical region)	0.000	0.997	0.003
C68.8 Overlapping lesion of urinary organs	0.002	0.997	0.000
C68.1 Paraurethral glands	0.002	0.997	0.000
J95.8 Other postprocedural respiratory disorders	0.003	0.997	0.000
Y42.4 Oral contraceptives	0.003	0.997	0.000
F33.0 Recurrent depressive disorder, current episode mild	0.000	0.997	0.003
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.000	0.997	0.002
Y52 Agents primarily affecting the cardiovascular system	0.003	0.997	0.000
C64 Malignant neoplasm of kidney, except renal pelvis	0.003	0.997	0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.000	0.997	0.002
M50.9 Cervical disk disorder, unspecified	0.000	0.997	0.002
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.002	0.997	0.000
N11 Chronic tubulo-interstitial nephritis	0.002	0.997	0.000
J31.0 Chronic rhinitis	0.000	0.998	0.002
M45.X9 Ankylosing spondylitis (Site unspecified)	0.002	0.998	0.000
Z22.3 Carrier of other specified bacterial diseases	0.000	0.998	0.002
Z85.8 Personal history of malignant neoplasms of other organs and systems	0.002	0.998	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.002	0.998	0.000
G96.0 Cerebrospinal fluid leak	0.002	0.998	0.000
Y42.2 Antithyroid drugs	0.002	0.998	0.000
M50 Cervical disk disorders	0.000	0.998	0.002
H50.9 Strabismus, unspecified	0.000	0.998	0.002
Z42.1 Follow-up care involving plastic surgery of breast	0.002	0.998	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
N11.0 Nonobstructive reflux-associated chronic pyelonephritis	0.002	0.998	0.000
Y42.1 Thyroid hormones and substitutes	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.002	0.998	0.000
M77.12 Lateral epicondylitis (Upper arm)	0.000	0.998	0.002
L27.0 Generalised skin eruption due to drugs and medicaments	0.002	0.998	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.002
Y42.7 Androgens and anabolic congeners	0.002	0.998	0.000
C65 Malignant neoplasm of renal pelvis	0.002	0.998	0.000
F31.0 Bipolar affective disorder, current episode hypomanic	0.000	0.998	0.002
Y43.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
F33.1 Recurrent depressive disorder, current episode moderate	0.000	0.998	0.002
N11.1 Chronic obstructive pyelonephritis	0.002	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
I84.4 External haemorrhoids with other complications	0.000	0.998	0.002
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.998	0.002
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
N11.8 Other chronic tubulo-interstitial nephritis	0.002	0.998	0.000
M50.2 Other cervical disk displacement	0.000	0.998	0.002
Y45.4 Antirheumatics	0.002	0.998	0.000
Y43 Primarily systemic agents	0.002	0.998	0.000
Y43.4 Immunosuppressive agents	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
D17.3 Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites	0.002	0.998	0.000
Y45.2 Propionic acid derivatives	0.002	0.998	0.000
J95 Postprocedural respiratory disorders, not elsewhere classified	0.002	0.998	0.000
Z22 Carrier of infectious disease	0.000	0.998	0.002
M54.49 Lumbago with sciatica (Site unspecified)	0.002	0.998	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.998	0.000
Z22.5 Carrier of viral hepatitis	0.000	0.998	0.002
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.002	0.998	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.002	0.998	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
Y45.0 Opioids and related analgesics	0.002	0.998	0.000
M50.8 Other cervical disk disorders	0.000	0.998	0.002
Y48.4 Anaesthetic, unspecified	0.002	0.998	0.000
Z42.9 Follow-up care involving plastic surgery, unspecified	0.002	0.998	0.000
Y45.1 Salicylates	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.002	0.998	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
M54.46 Lumbago with sciatica (Lumbar region)	0.002	0.998	0.000
G62.0 Drug-induced polyneuropathy	0.002	0.998	0.000
N80.1 Endometriosis of ovary	0.000	0.998	0.002
S41.1 Open wound of upper arm	0.000	0.998	0.002
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.002	0.998	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
O12.0 Gestational oedema	0.000	0.998	0.002
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
G60.0 Hereditary motor and sensory neuropathy	0.002	0.998	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
Y58 Bacterial vaccines	0.002	0.998	0.000
H35.7 Separation of retinal layers	0.002	0.998	0.000
I24.9 Acute ischaemic heart disease, unspecified	0.000	0.998	0.002
J95.5 Postprocedural subglottic stenosis	0.002	0.998	0.000
Y43.2 Antineoplastic natural products	0.002	0.998	0.000
Y45.8 Other analgesics and antipyretics	0.002	0.998	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y48.5 Therapeutic gases	0.002	0.998	0.000
Y48.1 Parenteral anaesthetics	0.002	0.998	0.000
Y48.0 Inhaled anaesthetics	0.002	0.998	0.000
A41.1 Septicaemia due to other specified staphylococcus	0.002	0.998	0.000
K72.1 Chronic hepatic failure	0.000	0.998	0.002
Y46.5 Valproic acid	0.002	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
Z51.4 Preparatory care for treatment, not elsewhere classified	0.002	0.998	0.000
Y43.9 Primarily systemic agent, unspecified	0.002	0.998	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.002	0.998	0.000
Y43.6 Enzymes, not elsewhere classified	0.002	0.998	0.000
Y43.5 Acidifying and alkalising agents	0.002	0.998	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.998	0.002
J39.8 Other specified diseases of upper respiratory tract	0.002	0.998	0.000
J99.8 Respiratory disorders in other diseases classified elsewhere	0.002	0.998	0.000
Y46.7 Anti-Parkinsonism drugs	0.002	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
Y59 Other and unspecified vaccines and biological substances	0.002	0.998	0.000
J95.0 Tracheostomy malfunction	0.002	0.998	0.000
Y43.1 Antineoplastic antimetabolites	0.002	0.998	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
Z22.1 Carrier of other intestinal infectious diseases	0.000	0.998	0.002
J95.4 Mendelson's syndrome	0.002	0.998	0.000
J95.3 Chronic pulmonary insufficiency following surgery	0.002	0.998	0.000
J95.1 Acute pulmonary insufficiency following thoracic surgery	0.002	0.998	0.000
K72.9 Hepatic failure, unspecified	0.000	0.998	0.002
Y50.9 Central nervous system stimulant, unspecified	0.001	0.998	0.000
Y50.8 Other central nervous system stimulants	0.001	0.998	0.000
Y50.1 Opioid receptor antagonists	0.001	0.998	0.000
Y50.0 Analeptics	0.001	0.998	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
Y51.0 Anticholinesterase agents	0.002	0.998	0.000
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
Z22.9 Carrier of infectious disease, unspecified	0.000	0.998	0.002
Z22.8 Carrier of other infectious diseases	0.000	0.998	0.002
Z22.6 Carrier of human T-lymphotropic virus type 1 [HTLV-1] infection	0.000	0.998	0.002
Z22.4 Carrier of infections with a predominantly sexual mode of transmission	0.000	0.998	0.002
Z22.2 Carrier of diphtheria	0.000	0.998	0.002
Z22.0 Carrier of typhoid	0.000	0.998	0.002
Y46.8 Antispasticity drugs	0.002	0.998	0.000
Y46.3 Deoxybarbiturates	0.002	0.998	0.000
Y46.1 Oxazolidinediones	0.002	0.998	0.000
Y46.0 Succinimides	0.002	0.998	0.000
Y56.9 Topical agent, unspecified	0.001	0.998	0.000
Y56.8 Other topical agents	0.001	0.998	0.000
Y56.7 Dental drugs, topically applied	0.001	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.001	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.001	0.998	0.000
Y56.2 Local astringents and local detergents	0.001	0.998	0.000
Y56.1 Antipruritics	0.001	0.998	0.000
I31 Other diseases of pericardium	0.000	0.998	0.002
J99 Respiratory disorders in diseases classified elsewhere	0.002	0.998	0.000
J95.2 Acute pulmonary insufficiency following nonthoracic surgery	0.001	0.998	0.000
Y46.6 Other and unspecified antiepileptics	0.002	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.001	0.998	0.000
Z29.8 Other specified prophylactic measures	0.000	0.998	0.002
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.001	0.998	0.000
Y40.8 Other systemic antibiotics	0.002	0.998	0.000
I31.1 Chronic constrictive pericarditis	0.000	0.998	0.002
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.001	0.998	0.000
Y46.4 Iminostilbenes	0.001	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.001	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.001	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.001	0.998	0.000
Y58.5 Diphtheria vaccine	0.001	0.998	0.000
Y58.4 Tetanus vaccine	0.001	0.998	0.000
Y58.3 Plague vaccine	0.001	0.998	0.000
Y58.2 Cholera vaccine	0.001	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.001	0.998	0.000
I27 Other pulmonary heart diseases	0.002	0.998	0.000
Y40 Systemic antibiotics	0.002	0.998	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.998	0.001
Y40.5 Aminoglycosides	0.001	0.998	0.000
H35 Other retinal disorders	0.002	0.998	0.000
I31.0 Chronic adhesive pericarditis	0.000	0.998	0.001
J99.1 Respiratory disorders in other diffuse connective tissue disorders	0.001	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.001	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.001	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.001	0.998	0.000
Y47.4 Bromine compounds	0.001	0.998	0.000
Y47.3 Paraldehyde	0.001	0.998	0.000
Y47.2 Chloral derivatives	0.001	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.001	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.001	0.998	0.000
J95.9 Postprocedural respiratory disorder, unspecified	0.001	0.998	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.998	0.001
Y46.2 Hydantoin derivatives	0.001	0.998	0.000
R47-R49 Symptoms and signs involving speech and voice	0.000	0.998	0.002
C34.3 Lower lobe, bronchus or lung	0.002	0.998	0.000
G83.4 Cauda equina syndrome	0.002	0.998	0.000
I82.9 Embolism and thrombosis of unspecified vein	0.000	0.998	0.002
N97.1 Female infertility of tubal origin	0.002	0.998	0.000
S05.8 Other injuries of eye and orbit	0.002	0.998	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.001
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.001
T46.7 Peripheral vasodilators	0.000	0.998	0.001
K72.0 Acute and subacute hepatic failure	0.000	0.998	0.001
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.001
Y59.9 Vaccine or biological substance, unspecified	0.001	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.001	0.998	0.000
Y59.2 Protozoal vaccines	0.001	0.998	0.000
Y59.1 Rickettsial vaccines	0.001	0.998	0.000
H35.6 Retinal haemorrhage	0.001	0.998	0.000
R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems	0.002	0.998	0.000
Y58.0 BCG vaccine	0.001	0.998	0.000
J95-J99 Other diseases of the respiratory system	0.002	0.998	0.000
H35.4 Peripheral retinal degeneration	0.001	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.001	0.998	0.000
Y55.0 Oxytocic drugs	0.001	0.998	0.000
G00 Bacterial meningitis, not elsewhere classified	0.000	0.998	0.001
J98 Other respiratory disorders	0.002	0.998	0.000
R48 Dyslexia and other symbolic dysfunctions, not elsewhere classified	0.000	0.998	0.001
Y53 Agents primarily affecting the gastro-intestinal system	0.001	0.998	0.000
B34.8 Other viral infections of unspecified site	0.000	0.999	0.001
I31.8 Other specified diseases of pericardium	0.000	0.999	0.001
I31.2 Haemopericardium, not elsewhere classified	0.000	0.999	0.001
Y40.6 Rifamycins	0.001	0.999	0.000
O72.0 Third-stage haemorrhage	0.000	0.999	0.001
Q54.0 Hypospadias, balanic	0.001	0.999	0.000
Y49.9 Psychotropic drug, unspecified	0.001	0.999	0.000
Y49.7 Psychostimulants with abuse potential	0.001	0.999	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.001	0.999	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.001	0.999	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.001	0.999	0.000
Y55.5 Anticommon cold drugs	0.001	0.999	0.000
Y55.3 Antitussives	0.001	0.999	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.001	0.999	0.000
Y59.3 Immunoglobulin	0.001	0.999	0.000
K72 Hepatic failure, not elsewhere classified	0.000	0.999	0.001
J99.0 Rheumatoid lung disease	0.001	0.999	0.000
K07.6 Temporomandibular joint disorders	0.001	0.999	0.000
T46.1 Calcium-channel blockers	0.000	0.999	0.001
Y40.7 Antifungal antibiotics, systemically used	0.001	0.999	0.000
Y47.1 Benzodiazepines	0.001	0.999	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.001	0.999	0.000
H35.2 Other proliferative retinopathy	0.001	0.999	0.000
I27.1 Kyphoscoliotic heart disease	0.001	0.999	0.000
M54.4 Lumbago with sciatica	0.001	0.999	0.000
Y40.4 Tetracyclines	0.001	0.999	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.001	0.999	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.001	0.999	0.000
Y55.4 Expectorants	0.001	0.999	0.000
M21.17 Varus deformity, not elsewhere classified (Ankle and foot)	0.001	0.999	0.000
M24.41 Recurrent dislocation and subluxation of joint (Shoulder region)	0.000	0.999	0.001
F01.9 Vascular dementia, unspecified	0.001	0.999	0.000
H35.1 Retinopathy of prematurity	0.001	0.999	0.000
H69.9 Eustachian tube disorder, unspecified	0.000	0.999	0.001
R48.0 Dyslexia and alexia	0.000	0.999	0.001
S05.1 Contusion of eyeball and orbital tissues	0.001	0.999	0.000
Y40.2 Chloramphenicol group	0.001	0.999	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.001	0.999	0.000
Y59.0 Viral vaccines	0.001	0.999	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.001	0.999	0.000
C34.2 Middle lobe, bronchus or lung	0.001	0.999	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.001	0.999	0.000
S13.4 Sprain and strain of cervical spine	0.000	0.999	0.001
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.999	0.001
Y44 Agents primarily affecting blood constituents	0.001	0.999	0.000
M24.27 Disorder of ligament (Ankle and foot)	0.001	0.999	0.000
B34.4 Papovirus infection, unspecified	0.000	0.999	0.001
G00.8 Other bacterial meningitis	0.000	0.999	0.001
G00.3 Staphylococcal meningitis	0.000	0.999	0.001
G00.0 Haemophilus meningitis	0.000	0.999	0.001
J98.5 Diseases of mediastinum, not elsewhere classified	0.001	0.999	0.000
J98.3 Compensatory emphysema	0.001	0.999	0.000
R48.8 Other and unspecified symbolic dysfunctions	0.000	0.999	0.001
Y40.3 Macrolides	0.001	0.999	0.000
Y53.2 Stimulant laxatives	0.001	0.999	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.001	0.999	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.001	0.999	0.001
J96 Respiratory failure, not elsewhere classified	0.001	0.999	0.000
M84.01 Malunion of fracture (Shoulder region)	0.001	0.999	0.000
I33.0 Acute and subacute infective endocarditis	0.001	0.999	0.000
R48.2 Apraxia	0.000	0.999	0.001
R48.1 Agnosia	0.000	0.999	0.001
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.001	0.999	0.000
Y53.7 Emetics	0.001	0.999	0.000
Y53.6 Antidiarrhoeal drugs	0.001	0.999	0.000
Y53.5 Digestants	0.001	0.999	0.000
Y53.0 Histamine H2-receptor antagonists	0.001	0.999	0.000
G00.2 Streptococcal meningitis	0.000	0.999	0.001
G62.9 Polyneuropathy, unspecified	0.001	0.999	0.000
I27.8 Other specified pulmonary heart diseases	0.001	0.999	0.000
J98.2 Interstitial emphysema	0.001	0.999	0.000
M77.1 Lateral epicondylitis	0.000	0.999	0.001
Y49.0 Tricyclic and tetracyclic antidepressants	0.001	0.999	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.001	0.999	0.000
G62 Other polyneuropathies	0.001	0.999	0.000
M54.48 Lumbago with sciatica (Sacral and sacrococcygeal region)	0.001	0.999	0.000
M54.45 Lumbago with sciatica (Thoracolumbar region)	0.001	0.999	0.000
M54.44 Lumbago with sciatica-Thoracic	0.001	0.999	0.000
M54.43 Lumbago with sciatica-Cervicothoracic	0.001	0.999	0.000
M54.42 Lumbago with sciatica-Cervical	0.001	0.999	0.000
M54.41 Lumbago with sciatica-Occipit-atl-axl	0.001	0.999	0.000
M54.40 Lumbago with sciatica (Multiple sites in spine)	0.001	0.999	0.000
C34.0 Main bronchus	0.001	0.999	0.000
D48.0 Bone and articular cartilage	0.001	0.999	0.000
G62.1 Alcoholic polyneuropathy	0.001	0.999	0.000
H35.5 Hereditary retinal dystrophy	0.001	0.999	0.000
S63.6 Sprain and strain of finger(s)	0.001	0.999	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.001	0.999	0.000
C34 Malignant neoplasm of bronchus and lung	0.001	0.999	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.000	0.999	0.001
J98.9 Respiratory disorder, unspecified	0.001	0.999	0.000
L27.2 Dermatitis due to ingested food	0.001	0.999	0.000
M84.0 Malunion of fracture	0.001	0.999	0.000
R16.1 Splenomegaly, not elsewhere classified	0.000	0.999	0.001
V89.2 Person injured in unspecified motor-vehicle accident, traffic	0.001	0.999	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.001	0.999	0.000
Y41.4 Anthelminthics	0.001	0.999	0.000
Y41.3 Other antiprotozoal drugs	0.001	0.999	0.000
Y44.6 Natural blood and blood products	0.001	0.999	0.000
G82.5 Tetraplegia, unspecified	0.001	0.999	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.001	0.999	0.000
Y44.7 Plasma substitutes	0.001	0.999	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.001	0.999	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.001	0.999	0.000
I31.9 Disease of pericardium, unspecified	0.000	0.999	0.001
J96.9 Respiratory failure, unspecified	0.001	0.999	0.000
J96.1 Chronic respiratory failure	0.001	0.999	0.000
J96.0 Acute respiratory failure	0.001	0.999	0.000
J98.6 Disorders of diaphragm	0.001	0.999	0.000
T79.3 Post-traumatic wound infection, not elsewhere classified	0.001	0.999	0.000
Y41.1 Antimycobacterial drugs	0.001	0.999	0.000
Y53.3 Saline and osmotic laxatives	0.001	0.999	0.000
M77.19 Lateral epicondylitis (Site unspecified)	0.000	0.999	0.001
M77.18 Lateral epicondylitis-Other	0.000	0.999	0.001
M77.17 Lateral epicondylitis-Ankle/Foot	0.000	0.999	0.001
M77.16 Lateral epicondylitis (Lower leg)	0.000	0.999	0.001
M77.15 Lateral epicondylitis (Pelvic region and thigh)	0.000	0.999	0.001
M77.14 Lateral epicondylitis-Hand	0.000	0.999	0.001
M77.11 Lateral epicondylitis-Shldr region	0.000	0.999	0.001
M77.10 Lateral epicondylitis (Multiple sites)	0.000	0.999	0.001
F31.9 Bipolar affective disorder, unspecified	0.000	0.999	0.001
G62.2 Polyneuropathy due to other toxic agents	0.001	0.999	0.000
R09.2 Respiratory arrest	0.001	0.999	0.000
T79.8 Other early complications of trauma	0.001	0.999	0.000
Y44.5 Thrombolytic drugs	0.001	0.999	0.000
Y49.2 Other and unspecified antidepressants	0.001	0.999	0.000
Z29.2 Other prophylactic chemotherapy	0.000	0.999	0.001
G60 Hereditary and idiopathic neuropathy	0.001	0.999	0.000
Z29 Need for other prophylactic measures	0.000	0.999	0.001
T79.5 Traumatic anuria	0.001	0.999	0.000
Y41.5 Antiviral drugs	0.001	0.999	0.000
Y53.4 Other laxatives	0.001	0.999	0.000
M77.13 Lateral epicondylitis-Forearm	0.000	0.999	0.001
M84.09 Malunion of fracture (Site unspecified)	0.001	0.999	0.000
M84.07 Malunion of fracture (Ankle and foot)	0.001	0.999	0.000
M84.00 Malunion of fracture (Multiple sites)	0.001	0.999	0.000
N18.2 Chronic kidney disease, stage 2	0.001	0.999	0.000
Y57.5 X-ray contrast media	0.000	0.999	0.001
M54.47 Lumbago with sciatica (Lumbosacral region)	0.001	0.999	0.000
G82.4 Spastic tetraplegia	0.001	0.999	0.000
I30.9 Acute pericarditis, unspecified	0.000	0.999	0.001
O30.0 Twin pregnancy	0.001	0.999	0.000
T79.6 Traumatic ischaemia of muscle	0.001	0.999	0.000
V49.5 Passenger injured in collision with other and unspecified motor vehicles in traffic accident	0.000	0.999	0.001
Y41.0 Sulphonamides	0.001	0.999	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.001	0.999	0.000
J96.09 Acute respiratory failure; Type unspecified	0.001	0.999	0.000
J96.01 Acute respiratory failure; Type II [hypercapnic]	0.001	0.999	0.000
J96.00 Acute respiratory failure; Type I [hypoxic]	0.001	0.999	0.000
J96.19 Chronic respiratory failure; Type unspecified	0.001	0.999	0.000
J96.11 Chronic respiratory failure; Type II [hypercapnic]	0.001	0.999	0.000
J96.10 Chronic respiratory failure; Type I [hypoxic]	0.001	0.999	0.000
J96.99 Respiratory failure, unspecified; Type unspecified	0.001	0.999	0.000
J96.91 Respiratory failure unspecified; Type II [hypercapnic]	0.001	0.999	0.000
J96.90 Respiratory failure, unspecified; Type I [hypoxic]	0.001	0.999	0.000
G82.2 Paraplegia, unspecified	0.001	0.999	0.000
T79.4 Traumatic shock	0.001	0.999	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.001	0.999	0.000
Z29.9 Prophylactic measure, unspecified	0.000	0.999	0.001
B34 Viral infection of unspecified site	0.000	0.999	0.001
T79 Certain early complications of trauma, not elsewhere classified	0.001	0.999	0.000
Y57 Other and unspecified drugs and medicaments	0.001	0.999	0.000
M84.06 Malunion of fracture (Lower leg)	0.001	0.999	0.000
M84.05 Malunion of fracture (Pelvic region and thigh)	0.001	0.999	0.000
M84.04 Malunion of fracture (Hand)	0.001	0.999	0.000
A04.8 Other specified bacterial intestinal infections	0.001	0.999	0.000
B34.9 Viral infection, unspecified	0.000	0.999	0.001
G60.3 Idiopathic progressive neuropathy	0.001	0.999	0.000
G60.2 Neuropathy in association with hereditary ataxia	0.001	0.999	0.000
G60.1 Refsum's disease	0.001	0.999	0.000
Q54.1 Hypospadias, penile	0.001	0.999	0.000
S65.1 Injury of radial artery at wrist and hand level	0.000	0.999	0.001
S65.0 Injury of ulnar artery at wrist and hand level	0.000	0.999	0.001
M80.00 Postmenopausal osteoporosis with pathological fracture (Multiple sites)	0.001	0.999	0.000
M84.08 Malunion of fracture (Other)	0.001	0.999	0.000
C34.1 Upper lobe, bronchus or lung	0.001	0.999	0.000
D09.0 Bladder	0.000	0.999	0.001
D11.0 Parotid gland	0.000	0.999	0.001
G00.9 Bacterial meningitis, unspecified	0.000	0.999	0.001
G60.9 Hereditary and idiopathic neuropathy, unspecified	0.001	0.999	0.000
I82.2 Embolism and thrombosis of vena cava	0.000	0.999	0.001
K29.0 Acute haemorrhagic gastritis	0.000	0.999	0.001
M45.X6 Ankylosing spondylitis (Lumbar region)	0.001	0.999	0.000
L27 Dermatitis due to substances taken internally	0.001	0.999	0.000
B34.2 Coronavirus infection, unspecified	0.000	0.999	0.001
B34.0 Adenovirus infection, unspecified	0.000	0.999	0.001
C34.8 Overlapping lesion of bronchus and lung	0.001	0.999	0.000
G96.8 Other specified disorders of central nervous system	0.001	0.999	0.000
M50.0 Cervical disk disorder with myelopathy	0.000	0.999	0.001
R09.1 Pleurisy	0.001	0.999	0.000
Z20.8 Contact with and exposure to other communicable diseases	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations